Pricing Log in Create free account

SciSparc Ltd. (SPRC) vs Valion Bio, Inc. (VBIO)

SciSparc Ltd. and Valion Bio, Inc. are both Biotechnology companies. Valion Bio, Inc. is the larger, with a market value of $1.1M against $880.0K — 1.2× the size. Across the 10 metrics below, SciSparc Ltd. leads on 7 and Valion Bio, Inc. on 3.

Valuation

Metric SPRC VBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.14 9.40
P/B n/m 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.13 n/m 0.66
EV/Sales n/m 11.09 9.02
Earnings yield (17,380.49%) (40,026.00%) (32.88%)
Free cash flow yield (160,955,097.92%) (22,510.36%) (23.13%)

Profitability

Metric SPRC VBIO Biotechnology median
Gross margin 0.00% (58.09%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (489.30%) (51.96%)
Return on assets 0.00% (104.96%) (46.06%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric SPRC VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 6.76%
EPS growth (last fiscal year) 51.90% 60.16% 29.88%
Revenue growth, 5-year CAGR — 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SPRC VBIO Biotechnology median
Debt to equity 0.24 0.62 0.00
Current ratio 0.87 1.11 4.97
Net debt to EBITDA 0.52 0.79 1.01

Dividend

Metric SPRC VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SPRC VBIO Biotechnology median
Market cap 880.00k 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack